Bridgelight Financial Advisors, Inc.’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$402K Buy
1,596
+72
+5% +$15.5K 0.28% 35
2026
Q1
$332K Buy
1,524
+37
+2% +$8.21K 0.28% 29
2025
Q4
$340K Buy
+1,487
New +$339K 0.29% 30

Other funds holding ABBV

Bridgelight Financial Advisors, Inc.'s ABBV Position: Q2 2026 in Review

Bridgelight Financial Advisors, Inc. increased its AbbVie (ABBV) stake by 4.7% in Q2 2026, buying an estimated $15.5K and bringing the position to 1,596 shares worth $402K. The position accounts for 0.28% of the portfolio, ranked #35.

Bridgelight Financial Advisors, Inc. first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 2,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bridgelight Financial Advisors, Inc. held 1,596 shares of AbbVie worth $402K as of Q2 2026.
  • Bridgelight Financial Advisors, Inc. bought 72 AbbVie shares in Q2 2026, an estimated $15.5K.
  • AbbVie made up 0.28% of Bridgelight Financial Advisors, Inc.'s portfolio in Q2 2026, its #35 holding.
  • Bridgelight Financial Advisors, Inc. first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 2,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bridgelight Financial Advisors, Inc.'s 13F filing for Q2 2026, filed 30 Jul 2026.